Intersecting discourses: MMR vaccine and bse

Science as Culture

Volumn 13, Issue 1, 2004, Pages 75-88

  Wilson, Chris ^a  

^a UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ANIMAL; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CATTLE; DRUG CONTAMINATION; ETHICS; GOVERNMENT; HEALTH CARE AND PUBLIC HEALTH; HUMAN; INTERPERSONAL COMMUNICATION; PRION DISEASE; RISK; TRUST; UNCERTAINTY; UNITED KINGDOM;

HEALTH CARE AND PUBLIC HEALTH;

ANIMALS; CATTLE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DISCLOSURE; DRUG CONTAMINATION; ENCEPHALOPATHY, BOVINE SPONGIFORM; GOVERNMENT; GREAT BRITAIN; HUMANS; MEASLES-MUMPS-RUBELLA VACCINE; PRION DISEASES; RISK; TRUST; UNCERTAINTY;

EID: 21744451834     PISSN: 09505431     EISSN: 14701189     Source Type: Journal    
DOI: 10.1080/0950543042000193780     Document Type: Article

References (19)

1. Afzal, MA, Minor, PD, and Schild, GC. (2000). ‘Clinical safety issues of measles, mumps and rubella vaccines’. Bulletin of the World Health Organization, 78(2):199–202.
2. Beale, AJ. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):906
3. Bedford, H, Booy, R, Dunn, D, DiGuiseppi, C, Gibb, D, Gilbert, R, Logan, S, Peckham, C, Roberts, I, and Tookey, P. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):907
4. Black, D, Prempeh, H, and Baxter, T. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):905–906.
5. BSE Inquiry Website:www.bse.org.uk
6. Hamilton, M. (2001). ‘The MMR vaccination and autism:a lay person’s contribution'. West Indian Medical Journal, 50(1):87–88.
7. Hilleman, MR. (1992). ‘Past, present, and future of measles, mumps, and rubella virus vaccines’. Pediatrics, 90(1):149–153.
8. Horton, A. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’, ‘Editor’s reply'. Lancet, 351(21 March):908–909.
9. Immunization Procedures, National Health and Medical Research Council (1991) 4th edition. Canberra:Australian Government Publishing Service
10. Lee, JW, Meigaard, B, Clements, CJ, Kane, M, Mulholland, EK, and Olive, JM. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):905
11. Lindley, KJ, and Milla, PJ. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):907–908.
12. O'Brien, SJ, Jones, IG, and Christie, P. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):906–907.
13. Payne, C, and Mason, B. (1998). ‘Autism, inflammatory bowel disease, and MMR vaccine’, ‘Correspondence’. Lancet, 351(21 March):907
14. Petit-Zeman S, (2002) ‘Most MMR studies are meaningless, investigation claims’ The Observer 6 October
15. The Pharmaceutical Journal (2002)) 269 (7724) 703
16. Stock S, (2002) ‘No evidence for claims’ The Australian 18 February:11
17. Thompson, KM. (2002). ‘Variability and uncertainty meet risk management and risk communication’. Risk Analysis, 22(3):647–654.
18. Wakefield, AJ, Murch, SH, Anthony, A, Linnell, J, Casson, DM, Malik, M, Dhillon, AP, Thomson, MA, Harvey, P, Valentine, A, Davies, SE, and Walker-Smith, JA. (1998). ‘Ileal-lymphoid-nodular hyperplasia, non- specific colitis, and pervasive developmental disorder in children’. Lancet, 351(28 February):637–641.
19. Walker, C, and Jacobs, S. (2002). ‘Social structures of science and approaches to outcomes-based medical research’. Critical Public Health, 12(4):309–320.